Migraine Briefs

Poor sleep and stress linked to higher headache recurrence in episodic migraine


 

Key clinical point: Poor sleep and higher stress level is associated with a higher rate of headache recurrence over next 6 weeks in patients with episodic migraine.

Major finding: Poor sleep quality was associated with a 22% higher rate of headache recurrence (adjusted hazard ratio [aHR], 1.22; 95% confidence interval [95% CI], 1.02-1.46), and the combination of poor sleep and moderate/high stress vs. good sleep and low stress was associated with a 31% higher rate of headache recurrence (aHR, 1.31; 95% CI, 1.05-1.65).

Study details: Findings are from a priori secondary analysis of a prospective cohort study of 98 patients with episodic migraine.

Disclosures: The work was funded by the National Institute of Neurological Disorders and Stroke, the American Sleep Medicine Foundation, the Harvard Clinical and Translational Science Center, and Harvard University and its affiliated academic health care centers. Dr. SM Bertisch reported receiving research support from and serving as a consultant for various sources. All other authors declared no financial conflicts of interest.

Source: Vgontzas A et al. Headache. 2021 Mar 22. doi: 10.1111/head.14105.

Recommended Reading

Type of bariatric surgery influences likelihood of migraine remission
Migraine ICYMI
Eptinezumab shows long-term safety and tolerability in chronic migraine
Migraine ICYMI
Chronic migraine: Addition of CGRP-targeted mAb to onabot further improves headache control
Migraine ICYMI
Patients with migraine more likely to report comorbidities and health problems
Migraine ICYMI
Migraine: Women have a higher prevalence of neck pain and cutaneous allodynia
Migraine ICYMI
Green light puts the stop on migraine
Migraine ICYMI
Ubrogepant safety and efficacy not affected by triptan therapy
Migraine ICYMI
Migraine: Anti-CGRP mAbs beneficial in partial and nonresponders to onabotulinumtoxinA
Migraine ICYMI
Prior exposure and response to triptans may not affect efficacy of ubrogepant
Migraine ICYMI
Celecoxib oral solution shows promise for acute treatment of migraine
Migraine ICYMI